LncRNA cancer susceptibility candidate 8 (CASC8) contributes to the progression of multiple types of cancer [105,106], and Wu et al. demonstrated the mechanisms of CASC8 upregulation as well as its effect on chemoresistance in ESCC. This evidence concerns the gene CASC8 and cancer.